Center-Authored Papers

Browse: Authors | Keywords | All Center-Authored Publications
Filter by Division: Basic | Clinical | Human Biology | PHS | VIDD (2010-present) | VIDI (2008-2009)
Filter by Year: 2008 | 2009 | 2010 | 2011 | 2012 | 2013

Filters: Keyword is Vaccine and Infectious Disease Division and Keyword is January 2013  [Clear All Filters]
B
Baggaley, RF, Dimitrov D, Owen BN, Pickles M, Butler AR, Masse B, Boily M-C.  2013.  Heterosexual Anal Intercourse: A Neglected Risk Factor for HIV? American journal of reproductive immunology (New York, N.Y. : 1989). 69 Suppl 1:95-105. Abstract
C
Chemaitelly, H, Shelton JD, Hallett TB, Abu-Raddad LJ.  2013.  Only a fraction of new HIV infections occur within identifiable stable discordant couples in sub-Saharan Africa.. AIDS (London, England). 27(2):251-60. Abstract
D
Dai, JY, Gilbert PB, Hughes JP, Brown ER.  2013.  Estimating the Efficacy of Preexposure Prophylaxis for HIV Prevention Among Participants With a Threshold Level of Drug Concentration.. American journal of epidemiology. 177(3):256-63. Abstract
Dimitrov, DT, Mâsse BR, Boily M-C.  2013.  Beating the placebo in HIV prevention efficacy trials: the role of the minimal efficacy bound.. Journal of acquired immune deficiency syndromes (1999). 62(1):95-101. Abstract
Drozd, DR, Limaye AP, Moss RB, Sanders RL, Hansen C, Edelman JD, Raghu G, Boeckh M, Rakita RM.  2013.  DAS181 treatment of severe parainfluenza type 3 pneumonia in a lung transplant recipient.. Transplant infectious disease : an official journal of the Transplantation Society. 15(1):E28-32. Abstract
Duerr, A, Huang Y, Buchbinder S, Coombs RW, Sanchez J, del Rio C, Casapia M, Santiago S, Huang Y, Gilbert P et al..  2013.  Reply to richie and villasante.. The Journal of infectious diseases. 207(4):690-2.
E
Etter, P, Landovitz R, Sibeko S, Sobieszczyk ME, Riddler SA, Karg C, Tsibris A, Schouten J.  2012.  Recommendations for the follow-up of study participants with breakthrough HIV infections during HIV/AIDS biomedical prevention studies.. AIDS (London, England). Abstract
F
Fogel, JM, Mwatha A, Richardson P, Brown ER, Chipato T, Alexandre M, Moodley D, Elbireer A, Mirochnick M, George K et al..  2012.  Impact of Maternal and Infant Antiretroviral Drug Regimens on Drug Resistance in HIV-Infected Breastfeeding Infants.. The Pediatric infectious disease journal. Abstract
H
Hodder, SL, Justman J, Hughes JP, Wang J, Haley DF, Adimora AA, del Rio C, Golin CE, Kuo I, Rompalo A et al..  2013.  HIV acquisition among women from selected areas of the United States: a cohort study.. Annals of internal medicine. 158(1):10-8. Abstract
Hoot, S, McGuire AT, Cohen KW, Strong RK, Hangartner L, Klein F, Diskin R, Scheid JF, Sather ND, Burton DR et al..  2013.  Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs.. PLoS pathogens. 9(1):e1003106. Abstract
J
Jhingran, A, Mar KB, Kumasaka DK, Knoblaugh SE, Ngo LY, Segal BH, Iwakura Y, Lowell CA, Hamerman JA, Lin X et al..  2012.  Tracing conidial fate and measuring host cell antifungal activity using a reporter of microbial viability in the lung.. Cell reports. 2(6):1762-73. Abstract
Jing, L, Schiffer JT, Chong TM, Bruckner JJ, Davies HD, Felgner PL, Haas J, Wald A, Verjans GMGM, Koelle DM.  2013.  CD4 T-cell memory responses to viral infections of humans show pronounced immunodominance independent of duration or viral persistence.. Journal of virology. 87(5):2617-27. Abstract
K
Kim, Y-J, Boeckh M, Cook L, Stempel H, Jerome KR, Boucek R, Burroughs L, Englund JA.  2012.  Cytomegalovirus infection and ganciclovir resistance caused by UL97 mutations in pediatric transplant recipients.. Transplant infectious disease : an official journal of the Transplantation Society. 14(6):611-7. Abstract
Kintu, K, Andrew P, Musoke P, Richardson P, Asiimwe-Kateera B, Nakyanzi T, Wang L, Fowler MG, Emel L, Ou S-S et al..  2012.  Feasibility and Safety of ALVAC-HIV vCP1521 Vaccine in HIV- exposed Infants in Uganda: Results from the First HIV Vaccine Trial in Infants in Africa.. Journal of acquired immune deficiency syndromes (1999). Abstract
Kublin, JG, Morgan CA, Day TA, Gilbert PB, Self SG, McElrath MJ, Corey L.  2012.  HIV Vaccine Trials Network: activities and achievements of the first decade and beyond.. Clinical investigation. 2(3):245-254. Abstract
L
Liu, MKP, Hawkins N, Ritchie AJ, Ganusov VV, Whale V, Brackenridge S, Li H, Pavlicek JW, Cai F, Rose-Abrahams M et al..  2013.  Vertical T cell immunodominance and epitope entropy determine HIV-1 escape.. The Journal of clinical investigation. 123(1):380-93. Abstract
M
Murnane, PM, Hughes JP, Celum C, Lingappa JR, Mugo N, Farquhar C, Kiarie J, Wald A, Baeten JM.  2012.  Using plasma viral load to guide antiretroviral therapy initiation to prevent HIV-1 transmission.. PloS one. 7(11):e51192. Abstract
S
Seo, S, Campbell AP, Xie H, Chien JW, Leisenring WM, Englund JA, Boeckh MJ.  2013.  Outcome of Respiratory Syncytial Virus Lower Respiratory Tract Disease in Hematopoietic Cell Transplant Recipients Receiving Aerosolized Ribavirin: Significance of Stem Cell Source and Oxygen Requirement.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Seo, S, Englund JA, Nguyen JT, Pukrittayakamee S, Lindegardh N, Tarning J, Tambyah PA, Renaud C, Went GT, de Jong MD et al..  2012.  Combination therapy with amantadine, oseltamivir, and ribavirin for influenza A infection: safety and pharmacokinetics.. Antiviral therapy. Abstract
Shepardson, KM, Ngo LY, Aimanianda V, Latge J-P, Barker BM, Blosser SJ, Iwakura Y, Hohl TM, Cramer RA.  2012.  Hypoxia enhances innate immune activation to Aspergillus fumigatus through cell wall modulation.. Microbes and infection / Institut Pasteur. Abstract
T
Tennant, BR, Robertson AG, Kramer M, Li L, Zhang X, Beach M, Thiessen N, Chiu R, Mungall K, Whiting CJ et al..  2013.  Identification and analysis of murine pancreatic islet enhancers.. Diabetologia. 56(3):542-52. Abstract
X
Xu, M, Qin X, Astion ML, Rutledge JC, Simpson J, Jerome KR, Englund JA, Zerr DM, Migita RT, Rich S et al..  2013.  Implementation of filmarray respiratory viral panel in a core laboratory improves testing turnaround time and patient care.. American journal of clinical pathology. 139(1):118-23. Abstract